Showing results (471-480 of 9,900) with videos related to

Sort By:
Pageof 990
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Bone Marrow Transplantation|February 1, 1996
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemiaA M Carella, F Chimirri, M Podestà, et al.
Bone Marrow Transplantation|February 1, 1996
Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD)R Nagler, Y Marmary, Y Krausz, et al.
Bone Marrow Transplantation|February 1, 1996
FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantationG Palka, L Stuppia, P Di Bartolomeo, et al.
Bone Marrow Transplantation|February 1, 1996
Paecilomyces varioti fungemia in a bone marrow transplant patientM M Shing, M Ip, C K Li, et al.
Bone Marrow Transplantation|May 1, 1993
Immunotherapy with interleukin 2 after ABMT in AMLM D Hamon, H G Prentice, D J Gottlieb, et al.
Bone Marrow Transplantation|March 1, 1993
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantationR Pene, F R Appelbaum, L Fisher, et al.
Bone Marrow Transplantation|October 1, 1995
Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questionsA M Marmont, D W Van Bekkum
Bone Marrow Transplantation|October 1, 1995
High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I studyR A Saez, R B Slease, C Strnad, et al.
Bone Marrow Transplantation|October 1, 1995
Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1A Ferrant, D Latinne, H Bazin, et al.
Pageof 990